Pakistan Science Abstracts
Choose Theme
1
2
3
4
Theme 1
— Green & Gold
Print
Save as PDF
Export BibTeX
Close
No Detail Found!
Home
›
Journal of Pakistan Association of Dermatologists
Efficacy and safety of omalizumab in the treatment of chronic urticaria: A case series
Author(s)
Asif Kamal
Department of Dermatology,Islamabad Medical Complex, NESCOM, Islamabad, Pakistan
Maryum Nouman
Department of Dermatology,Islamabad Medical Complex, NESCOM, Islamabad, Pakistan
Abstract
Chronic idiopathic urticaria (CIU) is a disease with significant impact on the quality of life owing to its morbidity and relative high prevalence. Omalizumab is a recombinant monoclonal antibody against IgE that inhibits binding of IgE to FceRI on the cell surface of mast cells. Its role has been thoroughly studied in asthma. We present a case series focusing on the role of subcutaneous omalizumab in the treatment of CIU along with its safety profile in terms of immediate and late side effects.
Publication Details
Page(s)
282-285
DOI
DOI not available
Published
Journal: Journal of Pakistan Association of Dermatologists, Volume: 27, Issue: 3, Year: 2017
Request the full text from PASTIC
Keywords
Chronic idiopathic urticaria, Omalizumab
More from
Journal of Pakistan Association of Dermatologists
Departmental case notes audit: A quality assurance measure in a changing organizational climate
Case of bullous pyoderma gangrenosum in a child
Clinical and pathological study of autoimmune vesiculobullous disorders
Ancient Schwannoma of oral cavity in a pediatric patient
Dermatological manifestations in patients with chronic kidney disease on regular hemodialysis
0
Citations
0
Downloads
90
Views